supported by the Institute of Health Carlos Ⅲ (Spain);co-financed by the European Union (DTS23/00010) for FMR。
BACKGROUND: Prehospital medication is a reality, and the role of these therapies must be explored to assess their validity, especially for acute respiratory diseases, which are usually associated with increased morbid...
funded by Agence Nationale de la Recherche'Résilience Covid-19'(ANR-21-COVR 0043).
Objectives To our best knowledge,no study in France has comprehensively investigated the prehospital history of patients admitted for severe cases of COVID-19.‘Patients’voice is an excellent means to capture data on...
BACKGROUND Coagulopathy and thromboembolic events are associated with poor outcomes in coronavirus disease 2019(COVID-19)patients.There is conflicting evidence on the effects of chronic anticoagulation on mortality an...